ソフォカルピジンの世界市場（～2026年）

• 英文タイトル：Global Sophocarpidine (CAS：519-02-8) Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY09865 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はソフォカルピジンのグローバル市場について調査・分析したレポートです。種類別（高純度、低純度）市場規模、用途別（医薬品、農薬、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ソフォカルピジンの競争状況、市場シェア ・世界のソフォカルピジン市場：種類別市場規模 2015年-2020年（高純度、低純度） ・世界のソフォカルピジン市場：種類別市場規模予測 2021年-2026年（高純度、低純度） ・世界のソフォカルピジン市場：用途別市場規模 2015年-2020年（医薬品、農薬、その他） ・世界のソフォカルピジン市場：用途別市場規模予測 2021年-2026年（医薬品、農薬、その他） ・北米のソフォカルピジン市場分析：米国、カナダ ・ヨーロッパのソフォカルピジン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのソフォカルピジン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のソフォカルピジン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのソフォカルピジン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Fujie Pharmaceutical、QHL Pharma、Select Botanical、Indena、TIANSHAN Pharmaceuticals、Selco Wirkstoffe Vertriebs GmbH、Jiangsu Tiansheng Pharmaceutical、Tiansheng Pharmaceutical、Hubei Zhongliao Chemical Co., LTD ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Sophocarpidine is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely used in the treatment of liver diseases.

Market Analysis and Insights: Global Sophocarpidine (CAS：519-02-8) Market
The global Sophocarpidine (CAS：519-02-8) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Sophocarpidine (CAS：519-02-8) Scope and Market Size
Sophocarpidine (CAS：519-02-8) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sophocarpidine (CAS：519-02-8) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Sophocarpidine (CAS：519-02-8) market is segmented into
High Purity
Low Purity

Segment by Application, the Sophocarpidine (CAS：519-02-8) market is segmented into
Pharmaceuticals
Pesticides
Others

Regional and Country-level Analysis
The Sophocarpidine (CAS：519-02-8) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sophocarpidine (CAS：519-02-8) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Sophocarpidine (CAS：519-02-8) Market Share Analysis
Sophocarpidine (CAS：519-02-8) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Sophocarpidine (CAS：519-02-8) business, the date to enter into the Sophocarpidine (CAS：519-02-8) market, Sophocarpidine (CAS：519-02-8) product introduction, recent developments, etc.

The major vendors covered:
Fujie Pharmaceutical
QHL Pharma
Select Botanical
Indena
TIANSHAN Pharmaceuticals
Selco Wirkstoffe Vertriebs GmbH
Jiangsu Tiansheng Pharmaceutical
Tiansheng Pharmaceutical
Hubei Zhongliao Chemical Co., LTD

レポート目次

---

1 Study Coverage
1.1 Sophocarpidine (CAS：519-02-8) Product Introduction
1.2 Market Segments
1.3 Key Sophocarpidine (CAS：519-02-8) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Sophocarpidine (CAS：519-02-8) Market Size Growth Rate by Type
1.4.2 High Purity
1.4.3 Low Purity
1.5 Market by Application
1.5.1 Global Sophocarpidine (CAS：519-02-8) Market Size Growth Rate by Application
1.5.2 Pharmaceuticals
1.5.3 Pesticides
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Sophocarpidine (CAS：519-02-8) Market Size, Estimates and Forecasts
2.1.1 Global Sophocarpidine (CAS：519-02-8) Revenue 2015-2026
2.1.2 Global Sophocarpidine (CAS：519-02-8) Sales 2015-2026
2.2 Global Sophocarpidine (CAS：519-02-8), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Sophocarpidine (CAS：519-02-8) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Sophocarpidine (CAS：519-02-8) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Sophocarpidine (CAS：519-02-8) Competitor Landscape by Players
3.1 Sophocarpidine (CAS：519-02-8) Sales by Manufacturers
3.1.1 Sophocarpidine (CAS：519-02-8) Sales by Manufacturers (2015-2020)
3.1.2 Sophocarpidine (CAS：519-02-8) Sales Market Share by Manufacturers (2015-2020)
3.2 Sophocarpidine (CAS：519-02-8) Revenue by Manufacturers
3.2.1 Sophocarpidine (CAS：519-02-8) Revenue by Manufacturers (2015-2020)
3.2.2 Sophocarpidine (CAS：519-02-8) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sophocarpidine (CAS：519-02-8) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Sophocarpidine (CAS：519-02-8) Revenue in 2019
3.2.5 Global Sophocarpidine (CAS：519-02-8) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Sophocarpidine (CAS：519-02-8) Price by Manufacturers
3.4 Sophocarpidine (CAS：519-02-8) Manufacturing Base Distribution, Product Types
3.4.1 Sophocarpidine (CAS：519-02-8) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sophocarpidine (CAS：519-02-8) Product Type
3.4.3 Date of International Manufacturers Enter into Sophocarpidine (CAS：519-02-8) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Sophocarpidine (CAS：519-02-8) Market Size by Type (2015-2020)
4.1.1 Global Sophocarpidine (CAS：519-02-8) Sales by Type (2015-2020)
4.1.2 Global Sophocarpidine (CAS：519-02-8) Revenue by Type (2015-2020)
4.1.3 Sophocarpidine (CAS：519-02-8) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Sophocarpidine (CAS：519-02-8) Market Size Forecast by Type (2021-2026)
4.2.1 Global Sophocarpidine (CAS：519-02-8) Sales Forecast by Type (2021-2026)
4.2.2 Global Sophocarpidine (CAS：519-02-8) Revenue Forecast by Type (2021-2026)
4.2.3 Sophocarpidine (CAS：519-02-8) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Sophocarpidine (CAS：519-02-8) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Sophocarpidine (CAS：519-02-8) Market Size by Application (2015-2020)
5.1.1 Global Sophocarpidine (CAS：519-02-8) Sales by Application (2015-2020)
5.1.2 Global Sophocarpidine (CAS：519-02-8) Revenue by Application (2015-2020)
5.1.3 Sophocarpidine (CAS：519-02-8) Price by Application (2015-2020)
5.2 Sophocarpidine (CAS：519-02-8) Market Size Forecast by Application (2021-2026)
5.2.1 Global Sophocarpidine (CAS：519-02-8) Sales Forecast by Application (2021-2026)
5.2.2 Global Sophocarpidine (CAS：519-02-8) Revenue Forecast by Application (2021-2026)
5.2.3 Global Sophocarpidine (CAS：519-02-8) Price Forecast by Application (2021-2026)

6 North America
6.1 North America Sophocarpidine (CAS：519-02-8) by Country
6.1.1 North America Sophocarpidine (CAS：519-02-8) Sales by Country
6.1.2 North America Sophocarpidine (CAS：519-02-8) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Sophocarpidine (CAS：519-02-8) Market Facts & Figures by Type
6.3 North America Sophocarpidine (CAS：519-02-8) Market Facts & Figures by Application

7 Europe
7.1 Europe Sophocarpidine (CAS：519-02-8) by Country
7.1.1 Europe Sophocarpidine (CAS：519-02-8) Sales by Country
7.1.2 Europe Sophocarpidine (CAS：519-02-8) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Sophocarpidine (CAS：519-02-8) Market Facts & Figures by Type
7.3 Europe Sophocarpidine (CAS：519-02-8) Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Sophocarpidine (CAS：519-02-8) by Region
8.1.1 Asia Pacific Sophocarpidine (CAS：519-02-8) Sales by Region
8.1.2 Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Sophocarpidine (CAS：519-02-8) Market Facts & Figures by Type
8.3 Asia Pacific Sophocarpidine (CAS：519-02-8) Market Facts & Figures by Application

9 Latin America
9.1 Latin America Sophocarpidine (CAS：519-02-8) by Country
9.1.1 Latin America Sophocarpidine (CAS：519-02-8) Sales by Country
9.1.2 Latin America Sophocarpidine (CAS：519-02-8) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Sophocarpidine (CAS：519-02-8) Market Facts & Figures by Type
9.3 Central & South America Sophocarpidine (CAS：519-02-8) Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Sophocarpidine (CAS：519-02-8) by Country
10.1.1 Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales by Country
10.1.2 Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Sophocarpidine (CAS：519-02-8) Market Facts & Figures by Type
10.3 Middle East and Africa Sophocarpidine (CAS：519-02-8) Market Facts & Figures by Application

11 Company Profiles
11.1 Fujie Pharmaceutical
11.1.1 Fujie Pharmaceutical Corporation Information
11.1.2 Fujie Pharmaceutical Description and Business Overview
11.1.3 Fujie Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Fujie Pharmaceutical Sophocarpidine (CAS：519-02-8) Products Offered
11.1.5 Fujie Pharmaceutical Related Developments
11.2 QHL Pharma
11.2.1 QHL Pharma Corporation Information
11.2.2 QHL Pharma Description and Business Overview
11.2.3 QHL Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 QHL Pharma Sophocarpidine (CAS：519-02-8) Products Offered
11.2.5 QHL Pharma Related Developments
11.3 Select Botanical
11.3.1 Select Botanical Corporation Information
11.3.2 Select Botanical Description and Business Overview
11.3.3 Select Botanical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Select Botanical Sophocarpidine (CAS：519-02-8) Products Offered
11.3.5 Select Botanical Related Developments
11.4 Indena
11.4.1 Indena Corporation Information
11.4.2 Indena Description and Business Overview
11.4.3 Indena Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Indena Sophocarpidine (CAS：519-02-8) Products Offered
11.4.5 Indena Related Developments
11.5 TIANSHAN Pharmaceuticals
11.5.1 TIANSHAN Pharmaceuticals Corporation Information
11.5.2 TIANSHAN Pharmaceuticals Description and Business Overview
11.5.3 TIANSHAN Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 TIANSHAN Pharmaceuticals Sophocarpidine (CAS：519-02-8) Products Offered
11.5.5 TIANSHAN Pharmaceuticals Related Developments
11.6 Selco Wirkstoffe Vertriebs GmbH
11.6.1 Selco Wirkstoffe Vertriebs GmbH Corporation Information
11.6.2 Selco Wirkstoffe Vertriebs GmbH Description and Business Overview
11.6.3 Selco Wirkstoffe Vertriebs GmbH Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS：519-02-8) Products Offered
11.6.5 Selco Wirkstoffe Vertriebs GmbH Related Developments
11.7 Jiangsu Tiansheng Pharmaceutical
11.7.1 Jiangsu Tiansheng Pharmaceutical Corporation Information
11.7.2 Jiangsu Tiansheng Pharmaceutical Description and Business Overview
11.7.3 Jiangsu Tiansheng Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Products Offered
11.7.5 Jiangsu Tiansheng Pharmaceutical Related Developments
11.8 Tiansheng Pharmaceutical
11.8.1 Tiansheng Pharmaceutical Corporation Information
11.8.2 Tiansheng Pharmaceutical Description and Business Overview
11.8.3 Tiansheng Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Products Offered
11.8.5 Tiansheng Pharmaceutical Related Developments
11.9 Hubei Zhongliao Chemical Co., LTD
11.9.1 Hubei Zhongliao Chemical Co., LTD Corporation Information
11.9.2 Hubei Zhongliao Chemical Co., LTD Description and Business Overview
11.9.3 Hubei Zhongliao Chemical Co., LTD Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS：519-02-8) Products Offered
11.9.5 Hubei Zhongliao Chemical Co., LTD Related Developments
11.1 Fujie Pharmaceutical
11.1.1 Fujie Pharmaceutical Corporation Information
11.1.2 Fujie Pharmaceutical Description and Business Overview
11.1.3 Fujie Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Fujie Pharmaceutical Sophocarpidine (CAS：519-02-8) Products Offered
11.1.5 Fujie Pharmaceutical Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Sophocarpidine (CAS：519-02-8) Market Estimates and Projections by Region
12.1.1 Global Sophocarpidine (CAS：519-02-8) Sales Forecast by Regions 2021-2026
12.1.2 Global Sophocarpidine (CAS：519-02-8) Revenue Forecast by Regions 2021-2026
12.2 North America Sophocarpidine (CAS：519-02-8) Market Size Forecast (2021-2026)
12.2.1 North America: Sophocarpidine (CAS：519-02-8) Sales Forecast (2021-2026)
12.2.2 North America: Sophocarpidine (CAS：519-02-8) Revenue Forecast (2021-2026)
12.2.3 North America: Sophocarpidine (CAS：519-02-8) Market Size Forecast by Country (2021-2026)
12.3 Europe Sophocarpidine (CAS：519-02-8) Market Size Forecast (2021-2026)
12.3.1 Europe: Sophocarpidine (CAS：519-02-8) Sales Forecast (2021-2026)
12.3.2 Europe: Sophocarpidine (CAS：519-02-8) Revenue Forecast (2021-2026)
12.3.3 Europe: Sophocarpidine (CAS：519-02-8) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Sophocarpidine (CAS：519-02-8) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Sophocarpidine (CAS：519-02-8) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Sophocarpidine (CAS：519-02-8) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Sophocarpidine (CAS：519-02-8) Market Size Forecast by Region (2021-2026)
12.5 Latin America Sophocarpidine (CAS：519-02-8) Market Size Forecast (2021-2026)
12.5.1 Latin America: Sophocarpidine (CAS：519-02-8) Sales Forecast (2021-2026)
12.5.2 Latin America: Sophocarpidine (CAS：519-02-8) Revenue Forecast (2021-2026)
12.5.3 Latin America: Sophocarpidine (CAS：519-02-8) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Sophocarpidine (CAS：519-02-8) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Sophocarpidine (CAS：519-02-8) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Sophocarpidine (CAS：519-02-8) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Sophocarpidine (CAS：519-02-8) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Sophocarpidine (CAS：519-02-8) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Sophocarpidine (CAS：519-02-8) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Sophocarpidine (CAS：519-02-8) Market Segments
Table 2. Ranking of Global Top Sophocarpidine (CAS：519-02-8) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sophocarpidine (CAS：519-02-8) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of High Purity
Table 5. Major Manufacturers of Low Purity
Table 6. Global Sophocarpidine (CAS：519-02-8) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Sophocarpidine (CAS：519-02-8) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Sophocarpidine (CAS：519-02-8) Sales by Regions 2015-2020 (K MT)
Table 9. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Regions (2015-2020)
Table 10. Global Sophocarpidine (CAS：519-02-8) Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Sophocarpidine (CAS：519-02-8) Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Sophocarpidine (CAS：519-02-8) Sales Share by Manufacturers (2015-2020)
Table 13. Global Sophocarpidine (CAS：519-02-8) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Sophocarpidine (CAS：519-02-8) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sophocarpidine (CAS：519-02-8) as of 2019)
Table 15. Sophocarpidine (CAS：519-02-8) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Sophocarpidine (CAS：519-02-8) Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Sophocarpidine (CAS：519-02-8) Price (2015-2020) (USD/MT)
Table 18. Sophocarpidine (CAS：519-02-8) Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Sophocarpidine (CAS：519-02-8) Product Type
Table 20. Date of International Manufacturers Enter into Sophocarpidine (CAS：519-02-8) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Sophocarpidine (CAS：519-02-8) Sales by Type (2015-2020) (K MT)
Table 23. Global Sophocarpidine (CAS：519-02-8) Sales Share by Type (2015-2020)
Table 24. Global Sophocarpidine (CAS：519-02-8) Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Sophocarpidine (CAS：519-02-8) Revenue Share by Type (2015-2020)
Table 26. Sophocarpidine (CAS：519-02-8) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Sophocarpidine (CAS：519-02-8) Sales by Application (2015-2020) (K MT)
Table 28. Global Sophocarpidine (CAS：519-02-8) Sales Share by Application (2015-2020)
Table 29. North America Sophocarpidine (CAS：519-02-8) Sales by Country (2015-2020) (K MT)
Table 30. North America Sophocarpidine (CAS：519-02-8) Sales Market Share by Country (2015-2020)
Table 31. North America Sophocarpidine (CAS：519-02-8) Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Sophocarpidine (CAS：519-02-8) Revenue Market Share by Country (2015-2020)
Table 33. North America Sophocarpidine (CAS：519-02-8) Sales by Type (2015-2020) (K MT)
Table 34. North America Sophocarpidine (CAS：519-02-8) Sales Market Share by Type (2015-2020)
Table 35. North America Sophocarpidine (CAS：519-02-8) Sales by Application (2015-2020) (K MT)
Table 36. North America Sophocarpidine (CAS：519-02-8) Sales Market Share by Application (2015-2020)
Table 37. Europe Sophocarpidine (CAS：519-02-8) Sales by Country (2015-2020) (K MT)
Table 38. Europe Sophocarpidine (CAS：519-02-8) Sales Market Share by Country (2015-2020)
Table 39. Europe Sophocarpidine (CAS：519-02-8) Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Sophocarpidine (CAS：519-02-8) Revenue Market Share by Country (2015-2020)
Table 41. Europe Sophocarpidine (CAS：519-02-8) Sales by Type (2015-2020) (K MT)
Table 42. Europe Sophocarpidine (CAS：519-02-8) Sales Market Share by Type (2015-2020)
Table 43. Europe Sophocarpidine (CAS：519-02-8) Sales by Application (2015-2020) (K MT)
Table 44. Europe Sophocarpidine (CAS：519-02-8) Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales Market Share by Application (2015-2020)
Table 53. Latin America Sophocarpidine (CAS：519-02-8) Sales by Country (2015-2020) (K MT)
Table 54. Latin America Sophocarpidine (CAS：519-02-8) Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Sophocarpidine (CAS：519-02-8) Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Sophocarpidine (CAS：519-02-8) Revenue Market Share by Country (2015-2020)
Table 57. Latin America Sophocarpidine (CAS：519-02-8) Sales by Type (2015-2020) (K MT)
Table 58. Latin America Sophocarpidine (CAS：519-02-8) Sales Market Share by Type (2015-2020)
Table 59. Latin America Sophocarpidine (CAS：519-02-8) Sales by Application (2015-2020) (K MT)
Table 60. Latin America Sophocarpidine (CAS：519-02-8) Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales Market Share by Application (2015-2020)
Table 69. Fujie Pharmaceutical Corporation Information
Table 70. Fujie Pharmaceutical Description and Major Businesses
Table 71. Fujie Pharmaceutical Sophocarpidine (CAS：519-02-8) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Fujie Pharmaceutical Product
Table 73. Fujie Pharmaceutical Recent Development
Table 74. QHL Pharma Corporation Information
Table 75. QHL Pharma Description and Major Businesses
Table 76. QHL Pharma Sophocarpidine (CAS：519-02-8) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. QHL Pharma Product
Table 78. QHL Pharma Recent Development
Table 79. Select Botanical Corporation Information
Table 80. Select Botanical Description and Major Businesses
Table 81. Select Botanical Sophocarpidine (CAS：519-02-8) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Select Botanical Product
Table 83. Select Botanical Recent Development
Table 84. Indena Corporation Information
Table 85. Indena Description and Major Businesses
Table 86. Indena Sophocarpidine (CAS：519-02-8) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Indena Product
Table 88. Indena Recent Development
Table 89. TIANSHAN Pharmaceuticals Corporation Information
Table 90. TIANSHAN Pharmaceuticals Description and Major Businesses
Table 91. TIANSHAN Pharmaceuticals Sophocarpidine (CAS：519-02-8) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. TIANSHAN Pharmaceuticals Product
Table 93. TIANSHAN Pharmaceuticals Recent Development
Table 94. Selco Wirkstoffe Vertriebs GmbH Corporation Information
Table 95. Selco Wirkstoffe Vertriebs GmbH Description and Major Businesses
Table 96. Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS：519-02-8) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Selco Wirkstoffe Vertriebs GmbH Product
Table 98. Selco Wirkstoffe Vertriebs GmbH Recent Development
Table 99. Jiangsu Tiansheng Pharmaceutical Corporation Information
Table 100. Jiangsu Tiansheng Pharmaceutical Description and Major Businesses
Table 101. Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Jiangsu Tiansheng Pharmaceutical Product
Table 103. Jiangsu Tiansheng Pharmaceutical Recent Development
Table 104. Tiansheng Pharmaceutical Corporation Information
Table 105. Tiansheng Pharmaceutical Description and Major Businesses
Table 106. Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Tiansheng Pharmaceutical Product
Table 108. Tiansheng Pharmaceutical Recent Development
Table 109. Hubei Zhongliao Chemical Co., LTD Corporation Information
Table 110. Hubei Zhongliao Chemical Co., LTD Description and Major Businesses
Table 111. Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS：519-02-8) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Hubei Zhongliao Chemical Co., LTD Product
Table 113. Hubei Zhongliao Chemical Co., LTD Recent Development
Table 114. Global Sophocarpidine (CAS：519-02-8) Sales Forecast by Regions (2021-2026) (K MT)
Table 115. Global Sophocarpidine (CAS：519-02-8) Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Sophocarpidine (CAS：519-02-8) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Sophocarpidine (CAS：519-02-8) Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Sophocarpidine (CAS：519-02-8) Sales Forecast by Country (2021-2026) (K MT)
Table 119. North America: Sophocarpidine (CAS：519-02-8) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Sophocarpidine (CAS：519-02-8) Sales Forecast by Country (2021-2026) (K MT)
Table 121. Europe: Sophocarpidine (CAS：519-02-8) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Sophocarpidine (CAS：519-02-8) Sales Forecast by Region (2021-2026) (K MT)
Table 123. Asia Pacific: Sophocarpidine (CAS：519-02-8) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Sophocarpidine (CAS：519-02-8) Sales Forecast by Country (2021-2026) (K MT)
Table 125. Latin America: Sophocarpidine (CAS：519-02-8) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Sophocarpidine (CAS：519-02-8) Sales Forecast by Country (2021-2026) (K MT)
Table 127. Middle East and Africa: Sophocarpidine (CAS：519-02-8) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Sophocarpidine (CAS：519-02-8) Players
Table 132. Sophocarpidine (CAS：519-02-8) Customers List
Table 133. Sophocarpidine (CAS：519-02-8) Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Sophocarpidine (CAS：519-02-8) Product Picture
Figure 2. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Type in 2020 & 2026
Figure 3. High Purity Product Picture
Figure 4. Low Purity Product Picture
Figure 5. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Application in 2020 & 2026
Figure 6. Pharmaceuticals
Figure 7. Pesticides
Figure 8. Others
Figure 9. Sophocarpidine (CAS：519-02-8) Report Years Considered
Figure 10. Global Sophocarpidine (CAS：519-02-8) Market Size 2015-2026 (US$ Million)
Figure 11. Global Sophocarpidine (CAS：519-02-8) Sales 2015-2026 (K MT)
Figure 12. Global Sophocarpidine (CAS：519-02-8) Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Region (2015-2020)
Figure 14. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Region in 2019
Figure 15. Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Region (2015-2020)
Figure 16. Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Region in 2019
Figure 17. Global Sophocarpidine (CAS：519-02-8) Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Sophocarpidine (CAS：519-02-8) Revenue in 2019
Figure 19. Sophocarpidine (CAS：519-02-8) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Type (2015-2020)
Figure 21. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Type in 2019
Figure 22. Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Type (2015-2020)
Figure 23. Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Type in 2019
Figure 24. Global Sophocarpidine (CAS：519-02-8) Market Share by Price Range (2015-2020)
Figure 25. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Application (2015-2020)
Figure 26. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Application in 2019
Figure 27. Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Application (2015-2020)
Figure 28. Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Application in 2019
Figure 29. North America Sophocarpidine (CAS：519-02-8) Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Sophocarpidine (CAS：519-02-8) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Sophocarpidine (CAS：519-02-8) Sales Market Share by Country in 2019
Figure 32. North America Sophocarpidine (CAS：519-02-8) Revenue Market Share by Country in 2019
Figure 33. U.S. Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Sophocarpidine (CAS：519-02-8) Market Share by Type in 2019
Figure 38. North America Sophocarpidine (CAS：519-02-8) Market Share by Application in 2019
Figure 39. Europe Sophocarpidine (CAS：519-02-8) Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Sophocarpidine (CAS：519-02-8) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Sophocarpidine (CAS：519-02-8) Sales Market Share by Country in 2019
Figure 42. Europe Sophocarpidine (CAS：519-02-8) Revenue Market Share by Country in 2019
Figure 43. Germany Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Sophocarpidine (CAS：519-02-8) Market Share by Type in 2019
Figure 54. Europe Sophocarpidine (CAS：519-02-8) Market Share by Application in 2019
Figure 55. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales Market Share by Region in 2019
Figure 58. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue Market Share by Region in 2019
Figure 59. China Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Sophocarpidine (CAS：519-02-8) Market Share by Type in 2019
Figure 82. Asia Pacific Sophocarpidine (CAS：519-02-8) Market Share by Application in 2019
Figure 83. Latin America Sophocarpidine (CAS：519-02-8) Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Sophocarpidine (CAS：519-02-8) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Sophocarpidine (CAS：519-02-8) Sales Market Share by Country in 2019
Figure 86. Latin America Sophocarpidine (CAS：519-02-8) Revenue Market Share by Country in 2019
Figure 87. Mexico Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Sophocarpidine (CAS：519-02-8) Market Share by Type in 2019
Figure 94. Latin America Sophocarpidine (CAS：519-02-8) Market Share by Application in 2019
Figure 95. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue Market Share by Country in 2019
Figure 99. Turkey Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Sophocarpidine (CAS：519-02-8) Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Sophocarpidine (CAS：519-02-8) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Sophocarpidine (CAS：519-02-8) Market Share by Type in 2019
Figure 106. Middle East and Africa Sophocarpidine (CAS：519-02-8) Market Share by Application in 2019
Figure 107. North America Sophocarpidine (CAS：519-02-8) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Sophocarpidine (CAS：519-02-8) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Sophocarpidine (CAS：519-02-8) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Sophocarpidine (CAS：519-02-8) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Sophocarpidine (CAS：519-02-8) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Sophocarpidine (CAS：519-02-8) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed

---